First drug to show both clinical symptomatic efficacy for five typical Omicron-related symptoms and antiviral efficacy SINGAPORE, Dec. 21, 2023 /PRNewswire/ — Singapore-headquartered Juniper Therapeutix, a science-led healthcare company focused on commercializing novel therapies, today…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.